UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2023
Commission File Number 001-15170
GSK plc
(Translation of registrant's name into English)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc
GSK publishes provisional dividend dates
GSK announces the following dividend dates for 2024:
These dates are indicative and may be subject to change.
Results | Announcement date | Ordinary Shares Ex-dividend date | American Depositary Shares Ex-dividend date | Record date | Last date for DRIP elections | Payable |
Q1 2024 | Wednesday 1 May 2024 | Thursday 16 May 2024 | Thursday 16 May 2024 | Friday 17 May 2024 | Thursday 20 June 2024 | Thursday 11 July 2024 |
Q2 2024 | Wednesday 31July 2024 | Thursday 15 August 2024 | Friday 16 August 2024 | Friday 16 August 2024 | Tuesday 19 September 2024 | Thursday 10 October 2024 |
Q3 2024 | Wednesday 30 October 2024 | Thursday 14 November 2024 | Friday 15 November 2024 | Friday 15 November 2024 | Monday 16 December 2024 | Thursday 9 January 2025 |
Q4 2024 | Wednesday 5 February 2025 | Thursday 20 February 2025 | Friday 21 February 2025 | Friday 21 February 2025 | Thursday 20 March 2025 | Thursday 10 April 2025 |
V A Whyte
Company Secretary
4 December 2023
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
GSK plc | |
(Registrant) | |
Date: December 4, 2023 | |
By:/s/ VICTORIA WHYTE -------------------------- | |
Victoria Whyte | |
Authorised Signatory for and on | |
behalf of GSK plc |